600 Anton Boulevard,
Costa Mesa, 92626, CA, United States
Nemus Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, NB1222 which is used for chemotherapy Induced nausea and vomiting, NB3111 for the treatment of methicillin-resistant staphylococcus aureus, NB2111 for treating chemotherapy Induced peripheral neuropathy and NB2222 used in the treatment of uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy.